ADC Therapeutics SA (ADCT)

NYSE: ADCT · Real-Time Price · USD

3.310

-0.020 (-0.60%)

At close: Sep 12, 2025, 4:00 PM EDT

3.370

+0.060 (1.81%)

After-hours: Sep 12, 2025, 7:25 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	2018 - 2019
Antibody Drug Conjugate Cancer Therapies	70.84M	Log In	Log In	Log In	Log In	Upgrade
Antibody Drug Conjugate Cancer Therapies Growth	1.84%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	2018 - 2019
United States	69.28M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	0.32%	Log In	Log In	Log In	Log In	Upgrade
EMEA	1.56M	Log In	Log In	Log In	Log In	Upgrade
EMEA Growth	212.65%	Log In	Log In	Log In	Log In	Upgrade